The information will be shared at the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) meeting.

Dianthus Therapeutics announces positive Phase II results for Claseprubart in myasthenia gravis, highlighting best-in-class potential.

Industry watchers who cheered on Summit Therapeutics’ claim that the first global phase 3 trial of its Akeso-partnered ...

Data to be presented in the Immunotherapy & Cell Therapy in Sarcoma: Emerging Frontiers session at the Connective Tissue Oncology Society ...

The September issue of LCGC International delivers new perspectives in oligonucleotide analysis, robust data statistics, and advanced workflows for complex biologics.

Gleneagles winning captain outlines the humble origins of the statistical work which will play a big role at Bethpage ...

FibroGen has agreed to pay $1.25 million to the Securities and Exchange Commission (SEC) to address allegations that the ...

Dr. Kurt Miceli, medical director for the advocacy group Do No Harm, presented at the CDC’s twice-yearly conference to update U.S. medical codes to include side effects for detransitioners, or those ...

In response to the needs of smart campus construction, Xi'an Medical College Library has officially launched a big data display platform, marking a solid step towards the digital and intelligent ...

The first look at August inflation—the Consumer Price Index—will show how price pressures are impacting the economy with ...

The detailed results from the HARMONi trial—the first global phase 3 data set for the world’s first PD-1xVEGF bispecific, ...

The statistics showed 88% of vehicle occupants use a seatbelt in Louisiana and a 18.3% decrease in DWI-related deaths.